Atherosclerosis is a leading cause of global mortality. Current clinically available imaging techniques suffer from limited spatial resolution and lack the ability to identify biomolecular features of atherosclerotic plaques. To address this, our team has developed a bimodal imaging system which consists of optical coherence tomography (OCT) and fluorescence. In addition, a nanoparticle named porphysomes is used as a fluorescence contrast agent to target macrophages in the plaques of diseased mice. Results suggest that our intravascular imaging system is capable of detecting the fluorescence from nanoparticles which provides complementary biological information to the structural information obtained from simultaneously-acquired OCT images.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.